Department of Health
and Human Services (HHS)
and Human Services (HHS)
October 29, 2020
PAR-18-427 - First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)
National Institute of Mental Health (NIMH)
This notice extends the expiration of PAR-18-427 "First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)". The dates have been modified to add one additional receipt date without AIDS due dates.
Changes to Key Dates apply to Part 1. Overview Information, Key Dates.
Current Expiration Date: January 8, 2021.
New Expiration Date: February 19, 2021.
Changes are reflected in bold italics as follows:
Changes to Key Dates
Currently Reads:
Part 1. Overview Information
Key Dates
| Posted Date | December 6, 2017 |
| Open Date (Earliest Submission Date) | January 5, 2018 |
| Letter of Intent Due Date(s) | 30 days prior to the application due date |
| Application Due Date(s) |
Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) |
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. The first AIDS due date for this FOA is May 7, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | Standard dates apply |
| Advisory Council Review | Standard dates apply |
| Earliest Start Date | Standard dates apply |
| Expiration Date | January 8, 2021 |
| Due Dates for E.O. 12372 | Not Applicable |
Modified to read:
Part 1. Overview Information
Key Dates
| Posted Date | December 6, 2017 |
| Open Date (Earliest Submission Date) | January 5, 2018 |
| Letter of Intent Due Date(s) | 30 days prior to the application due dates. |
| Application Due Date(s) |
February 18, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) |
Not Applicable |
| Scientific Merit Review | June 2021 |
| Advisory Council Review | October 2021 |
| Earliest Start Date | December 2021 |
| Expiration Date | February 19, 2021 |
| Due Dates for E.O. 12372 | Not Applicable |
All other aspects of this FOA remain unchanged.
Refer to the FOA for specific research contacts.